AXON Neuroscience
Phase 3AXON Neuroscience SE is a biotech company dedicated to the development of disease modifying immunotherapy and early diagnostics for Alzheimer's disease.
Founded
1999
Focus
Vaccines
About
AXON Neuroscience SE is a biotech company dedicated to the development of disease modifying immunotherapy and early diagnostics for Alzheimer's disease.
Funding History
2Total raised: $35M
Series B$25MPura Vida InvestmentsMar 15, 2022
Series A$10MUndisclosedJun 15, 2020
Company Info
TypePrivate
Founded1999
LocationBratislava, Europe - Other
StagePhase 3
Contact
SIMILAR COMPANIES
3D BioLabs
Pre-clinical · Sarajevo
Bilim Pharmaceuticals
Pre-clinical · Istanbul
3Z Pharmaceuticals
Pre-clinical · Reykjavik
ADAX
Pre-clinical · Ljubljana
Exolitus
Pre-clinical · Vienna
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile